Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Curtis Holt"'
Autor:
Edward J Gane, Rica Dagooc, Dominic Ray-Chaudhuri, Thomas Mules, Frida Abramov, Curtis Holt, Hongyuan Wang, Vithika Suri, Anu Osinusi, John F. Flaherty
Publikováno v:
Journal of Hepatology. 77:S837
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f53b8acbd6ad370283c4f858f7083c16
https://doi.org/10.1016/s0168-8278(22)01970-5
https://doi.org/10.1016/s0168-8278(22)01970-5
Publikováno v:
Expert Opinion on Pharmacotherapy. 16:2835-2848
The use of direct-acting antiviral (DAA) agents against chronic hepatitis C virus (HCV) infections can result in the successful treatment of nearly all patients. Effective antiviral treatments can prevent the progression to cirrhosis and hepatocellul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29a1030889331c1e5f7996d24b459735
https://doi.org/10.1517/14656566.2015.1114099
https://doi.org/10.1517/14656566.2015.1114099
Autor:
Curtis Holt
Publikováno v:
Anesthesiology clinics. 35(3)
Mechanisms of rejection, new pharmacologic approaches, and genomic medicine are major foci for current research in transplantation. It is hoped that these new agents and personalized immunosuppression will provide for less toxic regimens that are eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db5b2f30e153e6b9727361cec147f4c
https://pubmed.ncbi.nlm.nih.gov/28784214
https://pubmed.ncbi.nlm.nih.gov/28784214
Autor:
Jessica B. Stiles, Andrew M. Cameron, Sammy Saab, Johnny C. Hong, Goran B. Klintmalm, Jean C. Emond, Chris E. Freise, Michael A. Zimmerman, Curtis Holt, Robert S. Brown, Thresiamma Lukose, Matthew S. Chang, Igal Kam, R. Busuttil, James F. Trotter, Jeffrey Campsen, R. Mark Ghobrial
Publikováno v:
Clinical Transplantation. 27:829-837
Orthotopic liver transplantation (OLT) is the preferred treatment for selected patients with hepatitis B virus (HBV)-related liver disease. This study aimed to (i) define long-term outcomes following OLT for HBV; (ii) to quantify the incidence of HBV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f0bb59d91413e4a0ec50ef4340a5ca2
https://doi.org/10.1111/ctr.12224
https://doi.org/10.1111/ctr.12224
Autor:
Johnny C. Hong, Robert S. Brown, Ronald W. Busuttil, James F. Trotter, Jeffrey Campsen, Mark Ghobrial, Jean C. Emond, Goran B. Klintmalm, Igal Kam, Matthew S. Chang, Sammy Saab, Curtis Holt, Jessica B. Stiles, Andrew M. Cameron, Michael A. Zimmerman, Thresiamma Lukose, Chris E. Freise
Publikováno v:
Liver Transplantation. 19:1020-1029
Reinfection with hepatitis B virus (HBV) after liver transplantation (LT) may favor the recurrence of hepatocellular carcinoma (HCC), and combination therapy with hepatitis B immunoglobulin (HBIG) and nucleoside/nucleotide analogues may reduce HBV re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9875f6ad59fd5f92ade0e9e832eb7dc1
https://doi.org/10.1002/lt.23703
https://doi.org/10.1002/lt.23703
Autor:
Francisco Durazo, Steven-Huy B. Han, Shireena Desai, Amy C. McClune, D. Tsaoi, Leonard I. Goldstein, Curtis Holt, Ronald W. Busuttil, Sammy Saab, D. Farmer
Publikováno v:
American Journal of Transplantation. 11:511-517
Liver transplant recipients are at risk of developing recurrent hepatitis B after liver transplantation for hepatitis B virus (HBV)-related liver disease. We evaluated the efficacy of a new hepatitis B prophylaxis regimen involving conversion from at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e65ed9a07da0e0daf2c8d65f3a58014c
https://doi.org/10.1111/j.1600-6143.2010.03416.x
https://doi.org/10.1111/j.1600-6143.2010.03416.x
Autor:
Ronald W. Busuttil, Sue V. McDiarmid, Curtis Holt, Michael N. Weaver, Tony Chen, Hasan Yersiz, Douglas G. Farmer, Sammy Saab, Carlos Cao, Jeffery Gornbein, Steven Han, Francisco Durazo, Jonathan R. Hiatt, Gerald S. Lipshutz, Leonard I. Goldstein, Farin Amersi, Rafik M. Ghobrial, Sherilyn A. Gordon
Publikováno v:
Annals of Surgery. 241:905-918
Few studies have evaluated long-term outcomes after orthotopic liver transplantation (OLT). This work analyzes the experience of nearly 2 decades by the same team in a single center. Outcomes of OLT and factors affecting survival were analyzed.Retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e61ad292a16357b69b59cd61bc8e415e
https://doi.org/10.1097/01.sla.0000164077.77912.98
https://doi.org/10.1097/01.sla.0000164077.77912.98
Autor:
Rosemarie Gagliardi, Goran B. Klintmalm, E. Steve Woodle, Kirti Shetty, Alan Norman Langnas, Manal F. Abdelmalek, Igal Kam, Andreas G. Tzakis, Darla K. Granger, Curtis Holt, Michael R. Lucey
Publikováno v:
ResearcherID
A retrospective chart review of 1065 consecutive liver allograft recipients in 11 centers from January 1997 to September 1998 was performed. Patients were followed for 3 years or until graft loss. Patients received either tacrolimus (n = 594), cyclos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b4642a3758b8b35de926694bf93965
https://doi.org/10.1111/j.1600-6143.2005.00808.x
https://doi.org/10.1111/j.1600-6143.2005.00808.x
Autor:
Hasan Yersiz, Ronald W. Busuttil, Douglas G. Farmer, Steven Han, Cindy Lee, Ayman B. Ibrahim, Myron J. Tong, Francisco Durazo, Jonathan R. Hiatt, Alexander Shpaner, Karl T. Esrason, Leonard I. Goldstein, Zobair M. Younossi, Victor Wu, Curtis Holt, R. Mark Ghobrial, Sammy Saab
Publikováno v:
Liver Transplantation. 11:218-223
Previous studies have demonstrated an association between Child Turcotte-Pugh (CTP) class and impaired quality of life. However, the relationship between the model for end-stage liver disease (MELD) score and quality of life (QOL) has not been well s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcd8ef1ab7c334ae04a5e91d08d24d5a
https://doi.org/10.1002/lt.20345
https://doi.org/10.1002/lt.20345